Internal Medicine, Endocrinology, Diabetes, & Metabolism · Nesconset, NY
NPI
1598714354
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
57 Southern Boulevard, Suite 1
Nesconset, NY, 11767
Phone (631) 584-0069
Groups this clinician bills Medicare through
Medicare paid, 2024
$259K
7,454 services
Medicare patients, 2024
1,222
Average age 74
Drug cost, 2024
$5.7M
12,219 prescriptions
Company payments, 2025
$173
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Joseph Terrana was code J0897 (injection, denosumab, 1 mg), 1,620 times for 15 patients. In total Joseph Terrana billed 7,454 services in 21 codes, and Medicare paid $259K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-07-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 1,620 | 15 | $20.74 | $34K |
| 99214 Office E&M - Established | Office | 1,506 | 863 | $105.69 | $159K |
| 99213 Office E&M - Established | Office | 420 | 384 | $76.02 | $32K |
| 95251 Test - Miscellaneous | Office | 194 | 99 | $29.80 | $5,782 |
| 76536 Ultrasound - Nonspecific | Office | 162 | 157 | $93.50 | $15K |
| 36415 Venipuncture Blood Collection | Office | 88 | 73 | $8.55 | $753 |
| 96372 Injection Administration | Office | 54 | 26 | $11.65 | $629 |
| 83036 Blood Count | Office | 42 | 38 | $9.52 | $400 |
| 99204 Office E&M - New | Office | 32 | 32 | $131.56 | $4,210 |
| 82962 Clinical Chemistry | Office | 26 | 25 | $3.21 | $83.46 |
| 99203 Office E&M - New | Office | 22 | 22 | $93.49 | $2,057 |
| 95249 Test - Miscellaneous | Office | 18 | 17 | $62.58 | $1,126 |
| 99221 Hospital E&M - Initial | Facility | 14 | 14 | $75.23 | $1,053 |
| 10005 Other Organ Systems | Office | 12 | 11 | $124.45 | $1,493 |
| 76942 Ultrasound - Nonspecific | Office | 12 | 11 | $53.07 | $637 |
By year: 2022 $240K for 7,029 services; 2023 $247K for 7,443 services; 2024 $259K for 7,454 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 88 | 73 | $8.55 | $753 |
| 83036 Blood Count | 42 | 38 | $9.52 | $400 |
| 82962 Clinical Chemistry | 26 | 25 | $3.21 | $83.46 |
Medicare prescription drug claims, 2024
In 2024, the drug Joseph Terrana prescribed most often to Medicare patients was Levothyroxine Sodium, with 1,370 prescriptions and refills. In total Joseph Terrana wrote 12,219 Medicare prescriptions that cost $5.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 1,370 | 3,999 | 364 | $24K |
| Mounjaro Tirzepatide | 1,043 | 1,367 | 170 | $1.4M |
| Ozempic Semaglutide | 835 | 1,226 | 169 | $1.1M |
| Synthroid Levothyroxine Sodium | 832 | 2,348 | 216 | $59K |
| Metformin Hcl Generic | 732 | 2,110 | 220 | $5,261 |
| Jardiance Empagliflozin | 532 | 1,232 | 143 | $692K |
| Atorvastatin Calcium Generic | 406 | 1,179 | 121 | $4,115 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 357 | 976 | 142 | $34K |
| Metformin Hcl Er Metformin Hcl | 316 | 928 | 97 | $3,008 |
| Rosuvastatin Calcium Generic | 252 | 706 | 83 | $2,898 |
| Glimepiride Generic | 247 | 680 | 75 | $2,390 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 208 | 555 | 78 | $34K |
| Losartan Potassium Generic | 196 | 564 | 66 | $1,679 |
| Toujeo Max Solostar Insulin Glargine,hum.Rec.Anlog | 170 | 384 | 54 | $213K |
| Methimazole Generic | 161 | 418 | 46 | $1,812 |
Brand drugs: 5,769 claims; generic drugs: 5,751 claims; opioid claims: 48.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Joseph Terrana $173 ($173 in general payments such as food, travel and fees) from 2 companies. The largest payer was IBSA Pharma Inc. with $112.
| Company | Payments | Amount |
|---|---|---|
| IBSA Pharma Inc. | 3 | $112 |
| Xeris Pharmaceuticals, Inc. | 3 | $61.2 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.